1
Country: UK | Funding: $205.5M
Pulmocide develops inhaled medications for the treatment of viral and fungal respiratory tract infections. The company's lead drug, opelconazole, is in Phase 3 clinical trials for the treatment of patients with invasive pulmonary aspergillosis. Aspergillus is a genus of fungi whose spores are airborne and can cause severe, often life-threatening, lung disease in people with weakened immune systems or pre-existing lung conditions. Opelconazole has received several FDA approvals that may expedite its development and/or review, including orphan drug designation, fast-track designation, and qualified infectious disease product (QIDP) designation. It has also received orphan drug designation in the European Union.
Pulmocide develops inhaled medications for the treatment of viral and fungal respiratory tract infections. The company's lead drug, opelconazole, is in Phase 3 clinical trials for the treatment of patients with invasive pulmonary aspergillosis. Aspergillus is a genus of fungi whose spores are airborne and can cause severe, often life-threatening, lung disease in people with weakened immune systems or pre-existing lung conditions. Opelconazole has received several FDA approvals that may expedite its development and/or review, including orphan drug designation, fast-track designation, and qualified infectious disease product (QIDP) designation. It has also received orphan drug designation in the European Union.
2
Country: USA | Funding: $185.9M
AnaptysBio is a therapeutic antibody product company and the leader in the use of somatic hypermutation, or SHM, for antibody discovery and optimization. SHM is the body's natural process for generating potent antibodies to fight disease.
AnaptysBio is a therapeutic antibody product company and the leader in the use of somatic hypermutation, or SHM, for antibody discovery and optimization. SHM is the body's natural process for generating potent antibodies to fight disease.
3
Country: USA | Funding: $177M
GentiBio is a biotherapeutics company developing engineered regulatory T cells (EngTregs) programmed to treat autoimmune allergic diseases.
GentiBio is a biotherapeutics company developing engineered regulatory T cells (EngTregs) programmed to treat autoimmune allergic diseases.
4
Country: USA | Funding: $155M
Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, oral KIT inhibitor.
Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, oral KIT inhibitor.
5
Country: USA | Funding: $24.5M
Nectar builds a comprehensive, vertically integrated allergy healthcare platform leveraging data and clinical research.
Nectar builds a comprehensive, vertically integrated allergy healthcare platform leveraging data and clinical research.
6
Country: Cyprus | Funding: €10M
Liita Care is a MedTech company focused on Respiratory Health. We are committed to improve quality of life for patients and healthy consumers by developing and manufacturing new and better therapies and medical devices for respiratory health management.
Liita Care is a MedTech company focused on Respiratory Health. We are committed to improve quality of life for patients and healthy consumers by developing and manufacturing new and better therapies and medical devices for respiratory health management.
7
Country: USA | Funding: $9M
Sound Health uses acoustic resonance to provide nasal relief.
Sound Health uses acoustic resonance to provide nasal relief.
8
Country: USA | Funding: $5.6M
Allergy Amulet is the world’s smallest and fastest consumer food allergen sensor, testing for common allergenic ingredients in seconds.
Allergy Amulet is the world’s smallest and fastest consumer food allergen sensor, testing for common allergenic ingredients in seconds.
